Edap Tms (NASDAQ:EDAP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP) in a report released on Wednesday. The brokerage issued a hold rating on the medical equipment provider’s stock.

Several other analysts also recently issued reports on EDAP. HC Wainwright restated a “buy” rating and issued a $19.00 price target on shares of Edap Tms in a research note on Friday, March 28th. Jefferies Financial Group restated a “hold” rating and set a $2.00 price objective (down from $8.00) on shares of Edap Tms in a research report on Friday, April 4th. Finally, Piper Sandler cut their target price on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday, March 28th.

Edap Tms Stock Up 0.5 %

Shares of EDAP stock opened at $2.22 on Wednesday. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The firm’s fifty day moving average price is $1.96 and its two-hundred day moving average price is $2.27. The firm has a market capitalization of $82.37 million, a P/E ratio of -3.42 and a beta of 0.13. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.14.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. The company had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, equities analysts predict that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Illumine Investment Management LLC acquired a new stake in shares of Edap Tms during the fourth quarter worth $50,000. Rock Springs Capital Management LP lifted its holdings in shares of Edap Tms by 1.5% in the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after purchasing an additional 23,800 shares in the last quarter. Schonfeld Strategic Advisors LLC boosted its holdings in Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after acquiring an additional 52,500 shares during the last quarter. Jane Street Group LLC grew its position in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73,361 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its holdings in shares of Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares in the last quarter. 62.74% of the stock is owned by institutional investors and hedge funds.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.